These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29659889)

  • 41. Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra Leone.
    Shantha JG; Mattia JG; Goba A; Barnes KG; Ebrahim FK; Kraft CS; Hayek BR; Hartnett JN; Shaffer JG; Schieffelin JS; Sandi JD; Momoh M; Jalloh S; Grant DS; Dierberg K; Chang J; Mishra S; Chan AK; Fowler R; O'Dempsey T; Kaluma E; Hendricks T; Reiners R; Reiners M; Gess LA; ONeill K; Kamara S; Wurie A; Mansaray M; Acharya NR; Liu WJ; Bavari S; Palacios G; Teshome M; Crozier I; Farmer PE; Uyeki TM; Bausch DG; Garry RF; Vandy MJ; Yeh S
    EBioMedicine; 2018 Apr; 30():217-224. PubMed ID: 29622497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone.
    Ji YJ; Duan XZ; Gao XD; Li L; Li C; Ji D; Li WG; Wang LF; Meng YH; Yang X; Ling BF; Song XA; Gu ML; Jiang T; Koroma SM; Bangalie J; Duan HJ
    Infect Dis Poverty; 2016 Nov; 5(1):101. PubMed ID: 27806732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.
    Cross RW; Boisen ML; Millett MM; Nelson DS; Oottamasathien D; Hartnett JN; Jones AB; Goba A; Momoh M; Fullah M; Bornholdt ZA; Fusco ML; Abelson DM; Oda S; Brown BL; Pham H; Rowland MM; Agans KN; Geisbert JB; Heinrich ML; Kulakosky PC; Shaffer JG; Schieffelin JS; Kargbo B; Gbetuwa M; Gevao SM; Wilson RB; Saphire EO; Pitts KR; Khan SH; Grant DS; Geisbert TW; Branco LM; Garry RF
    J Infect Dis; 2016 Oct; 214(suppl 3):S210-S217. PubMed ID: 27587634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
    Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Chanfreau Munoz V; Doumbouya L; Souley Harouna ; Kighoma PM; Koundouno FR; Réné Lolamou ; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; Wölfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Gasasira Uwamahoro M; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; Barte de Sainte Fare E; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Allaford Duverger T; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; Günther S; de Lamballerie X; Keïta S; Mentre F; Anglaret X; Malvy D;
    PLoS Med; 2016 Mar; 13(3):e1001967. PubMed ID: 26930627
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment and Optimization of the GeneXpert Diagnostic Platform for Detection of Ebola Virus RNA in Seminal Fluid.
    Pettitt J; Higgs E; Fallah M; Nason M; Stavale E; Marchand J; Reilly C; Jensen K; Dighero-Kemp B; Tuznik K; Logue J; Bolay F; Hensley L
    J Infect Dis; 2017 Feb; 215(4):547-553. PubMed ID: 28003349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus.
    Ayouba A; Touré A; Butel C; Keita AK; Binetruy F; Sow MS; Foulongne V; Delaporte E; Peeters M
    J Clin Microbiol; 2017 Jan; 55(1):165-176. PubMed ID: 27795350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of an antigen detection assay for early point-of-care diagnosis of Zaire ebolavirus.
    DeMers HL; He S; Pandit SG; Hannah EE; Zhang Z; Yan F; Green HR; Reyes DF; Hau D; McLarty ME; Altamura L; Taylor-Howell C; Gates-Hollingsworth MA; Qiu X; AuCoin DP
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008817. PubMed ID: 33141837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans.
    Rijal P; Elias SC; Machado SR; Xiao J; Schimanski L; O'Dowd V; Baker T; Barry E; Mendelsohn SC; Cherry CJ; Jin J; Labbé GM; Donnellan FR; Rampling T; Dowall S; Rayner E; Findlay-Wilson S; Carroll M; Guo J; Xu XN; Huang KA; Takada A; Burgess G; McMillan D; Popplewell A; Lightwood DJ; Draper SJ; Townsend AR
    Cell Rep; 2019 Apr; 27(1):172-186.e7. PubMed ID: 30943399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea.
    van Griensven J; Edwards T; de Lamballerie X; Semple MG; Gallian P; Baize S; Horby PW; Raoul H; Magassouba N; Antierens A; Lomas C; Faye O; Sall AA; Fransen K; Buyze J; Ravinetto R; Tiberghien P; Claeys Y; De Crop M; Lynen L; Bah EI; Smith PG; Delamou A; De Weggheleire A; Haba N;
    N Engl J Med; 2016 Jan; 374(1):33-42. PubMed ID: 26735992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study.
    Aviles J; Bello A; Wong G; Fausther-Bovendo H; Qiu X; Kobinger G
    J Infect Dis; 2015 Oct; 212 Suppl 2():S389-97. PubMed ID: 26038398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Open-label phase I clinical trial of Ad5-EBOV in Africans in China.
    Wu L; Zhang Z; Gao H; Li Y; Hou L; Yao H; Wu S; Liu J; Wang L; Zhai Y; Ou H; Lin M; Wu X; Liu J; Lang G; Xin Q; Wu G; Luo L; Liu P; Shentu J; Wu N; Sheng J; Qiu Y; Chen W; Li L
    Hum Vaccin Immunother; 2017 Sep; 13(9):2078-2085. PubMed ID: 28708962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential requirements for FcγR engagement by protective antibodies against Ebola virus.
    Bournazos S; DiLillo DJ; Goff AJ; Glass PJ; Ravetch JV
    Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20054-20062. PubMed ID: 31484758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea.
    Vernet MA; Reynard S; Fizet A; Schaeffer J; Pannetier D; Guedj J; Rives M; Georges N; Garcia-Bonnet N; Sylla AI; Grovogui P; Kerherve JY; Savio C; Savio-Coste S; de Séverac ML; Zloczewski P; Linares S; Harouna S; Abdoul BM; Petitjean F; Samake N; Shepherd S; Kinda M; Koundouno FR; Joxe L; Mateo M; Lecine P; Page A; Tchamdja TM; Schoenhals M; Barbe S; Simon B; Tran-Minh T; Longuet C; L'Hériteau F; Baize S
    JCI Insight; 2017 Mar; 2(6):e88864. PubMed ID: 28352651
    [No Abstract]   [Full Text] [Related]  

  • 54. Modelling Ebola virus dynamics: Implications for therapy.
    Martyushev A; Nakaoka S; Sato K; Noda T; Iwami S
    Antiviral Res; 2016 Nov; 135():62-73. PubMed ID: 27743917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ebola Virus Persistence in Semen of Male Survivors.
    Uyeki TM; Erickson BR; Brown S; McElroy AK; Cannon D; Gibbons A; Sealy T; Kainulainen MH; Schuh AJ; Kraft CS; Mehta AK; Lyon GM; Varkey JB; Ribner BS; Ellison RT; Carmody E; Nau GJ; Spiropoulou C; Nichol ST; Ströher U
    Clin Infect Dis; 2016 Jun; 62(12):1552-1555. PubMed ID: 27045122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expanding the watch list for potential Ebola virus antibody escape mutations.
    Patel JS; Quates CJ; Johnson EL; Ytreberg FM
    PLoS One; 2019; 14(3):e0211093. PubMed ID: 30897171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study.
    Halfmann PJ; Eisfeld AJ; Watanabe T; Maemura T; Yamashita M; Fukuyama S; Armbrust T; Rozich I; N'jai A; Neumann G; Kawaoka Y; Sahr F
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007654. PubMed ID: 31369554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and Evaluation of a Rapid and Sensitive EBOV-RPA Test for Rapid Diagnosis of Ebola Virus Disease.
    Yang M; Ke Y; Wang X; Ren H; Liu W; Lu H; Zhang W; Liu S; Chang G; Tian S; Wang L; Huang L; Liu C; Yang R; Chen Z
    Sci Rep; 2016 Jun; 6():26943. PubMed ID: 27246147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolution and Spread of Ebola Virus in Liberia, 2014-2015.
    Ladner JT; Wiley MR; Mate S; Dudas G; Prieto K; Lovett S; Nagle ER; Beitzel B; Gilbert ML; Fakoli L; Diclaro JW; Schoepp RJ; Fair J; Kuhn JH; Hensley LE; Park DJ; Sabeti PC; Rambaut A; Sanchez-Lockhart M; Bolay FK; Kugelman JR; Palacios G
    Cell Host Microbe; 2015 Dec; 18(6):659-69. PubMed ID: 26651942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody.
    Parren PW; Geisbert TW; Maruyama T; Jahrling PB; Burton DR
    J Virol; 2002 Jun; 76(12):6408-12. PubMed ID: 12021376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.